ABCDEFGHIJKLMNOPQRSTUVWXYZAAABACADAE
1
2
NameOrganizationEmail address1st area of interest2nd area of interest3rd area of interest4th area of interestComments and suggestionsWhat steps are the organization that you represent currently taking?Any others steps?Please clarify and address scope
3
1Daved Rosensweet MDThe Menopause Methoddrr@menopausemethod.comSteering CommitteeCoalition-BuildingMessaging/CommunicationsMedical StudiesSpecial interest in Documentary Film. Create hormone treatment of women in men in climacteric as a Board Specialization, with Standards of CareSteering CommitteeCoalition-Building
4
2Carol PetersenThe Wellness by Design Projectcarollp@aol.comSteering CommitteeLegalMessaging/CommunicationsAdvocacy [Lobbying]Special interest in contacting Influencers
5
3Scott BrunnerAlliance for Pharmacy Compoundingscott@a4pc.orgSteering CommitteeMessaging/CommunicationsMobilization/Grassroots
6
4Jerry Gillick, RPhCollege Pharmacyjerry@collegepharmacy.comSteering CommitteeLegalCoalition-BuildingSpecial interest in coalition website and Core values and MissionFOIA Request
7
5Karen Leggett DOWomen's Midlife Specialistdrleggett@drkarenleggett.comMobilization/GrassrootsMedical StudiesMessaging/Communications1. Under Grass Roots: a. I would contact authors of books about compounded hormones. These people are likely to have FB and email subscribers they can contact. b. If a computer program is available on line for these people which identifies and sends a pre-written letter (which can be edited if they like) to their congressmen (and the White House) then this project would be incorporating a successful technique. 2. Under "Medical Studies" as a committee member, I like reading and studying medical studies published in peer reviewed journals, so this is a good job for me. 3. Under "Documentary" committee member, I could help with ideas through offering studies published in peer reviewed journals, and even interviews with women and their experiences - show the emotional side. I could interview women on zoom. 4. Under Core Values / Mission: I could offer working toward a narrow concise Mission statement as well as concise, numbered core values. As for the amount of time I can offer, I need to have a better understanding our TIME Frame and Requirements. Short term I can delegate some things or put this as higher priority, but long term, this is different. I need time frames to give you a better idea of the maximum time I can give. Thank you. Karen Leggett DOI have a twice weekly newsletter and a small (5000 +) Facebook following.
8
6Devaki Lindsey Berkson clinician Naple's podcast blogger dlberkson@gmail.comMessaging/CommunicationsSteering CommitteeVery interested in documentary, being a blogger, and trying to find out about a possible conflict of interest re "Replenish," a new product FDA approved of oral estradiol plus progesterone...they are rising into the market at the same time the FDA commissioned NASEM...is there substance to this conflict?
9
7Dian Ginsberg MDOB/Gyn /functional meddian@theginstitiuteofm.comMedical StudiesMedical StudiesMessaging/CommunicationsDocumentaryDocumentary film
10
8Phyllis Bronson, Ph.D.Biochemical Research FDN/ COPhyllis Bronson Phd@me.comMedical StudiesMedical StudiesSteering Committeemany women read my articles and book, spoken at ICIM and for years at Orthomolecular connecting BHRT/ mood biochemistry
11
9Jo TwomblyAlliance for Natural Health USAjo@anh-usa.orgSteering CommitteeMobilization/GrassrootsAdvocacy [Lobbying]Coalition, WebsiteProtecting access to bioidenticals is a top priority for ANH. We have taken a number of actions to support this campaign over the years, including leading grassroots action to Congress and the FDA with the support of newsletter articles, social media posts, print and online advertisements, printed flyers, and other tactics.
12
10Aaron LopezPolitical Capital LLCaaron@politicalcapitalllc.comAdvocacy [Lobbying]LegalMessaging/CommunicationsInterested in Comprehensive response to NASEM findings
13
11Jim Hrncir RPhLas Colinas Pharmacylascolrx@aol.comMedical StudiesMessaging/CommunicationsLegalDocumentaryInterested in Comprehensive response to NASEM findings plus Documentary#1- find a resource to evaluate existing studies commonly used by cBHRT pracs to validate their therapy choices. #2- design a study with data points to allow practitioners to easily fill in with existing patient cases. I like the idea of separate arms for each treatment protocol based on therapy or testing method- Saliva, Serum, Urine, Pellets, Wiley, Blood spot?
14
12Joshua RosensweetInstitute of Hormone Replacement Therapyjr@menopausemethod.comMessaging/CommunicationsCoalition-Building
15
13Bruce BiundoPCCAbbiiundo@pccarx.comMedical StudiesMessaging/CommunicationsMobilization/Grassroots
16
14Alan DumoffIMCalandlmc@aol.comLegalMessaging/CommunicationsSteering CommitteeCoalition-BuildingInterested in clear messaging/response to NASEM; administrative preparation for FDA actionsIMC has been the only group directly challenging FDA's other main compouding ingredient restrictions on PCAC/DQSA reviews for compounded drugs through a Citizen's Petition avialable on the FDA docket at https://www.regulations.gov/document?D=FDA-2019-P-1351-0001
17
15Stephen SnowBendin Sumrall & Ladner, LLCssnow@bsllaw.netlegalMessaging/CommunicationsSteering CommitteeMobilization/Grassroots
18
16Evan SchrodeBendin Sumrall & Ladner, LLCeschrode@bsllaw.netlegalMessaging/CommunicationsSteering CommitteeMobilization/Grassroots
19
17Laura FarrAmerican Association of Naturopathic Physiciansexecutive@naturopathic.orgMobilization/GrassrootsMessaging/CommunicationsAdvocacy [Lobbying]
20
18Melika ZandAmerican Association of Naturopathic Physiciansprograms@naturopathic.orgMobilization/GrassrootsAdvocacy [Lobbying]Coalition-BuildingMessaging/Communications
21
19Jeffrey DachICIMdrdach@drdach.comEditorial
22
20David PoreHance Scarborough LLP (APC)dpore@hslawmail.comAdvocacy [Lobbying]LegalMessaging/CommunicationsCoalition-Building
23
21Shawn HodgesAlliance for Pharmacy Compoundingshodges@innovationcompounding.comSteering CommitteeCoalition-Building
24
22Gina BestemanWomen's International Pharmacy and APC cBHRT Task Force Chairgina@womensinternational.comSteering CommitteeMedical StudiesLegalMobilization/Grassroots
25
23Patrick HanawayInstitute for Functional Medicinepatrickhanaway@ifm.orgMedical StudiesCertification/ Standards of CareCreate hormone treatment of women in men in climacteric as a Board Specialization, with Standards of Care
26
27
24Jim RockRock & Associatesjameswrock@mac.comAdvocay/LobbyingMessaging/CommunicationsMobilization/GrassrootsLegal
28
25E.R. Shippen M.D.ershippen@icloud.comMedical StudiesMessaging/Communications
29
26Wanda R. Minnis-Dyson M.D.Change for Life Wellness & Aestheticsdocdyson@aol.comMedia
30
27Sheila Sawyer MDSheila Sawyer MD IFMCP Menopause Methodsheilasawyermd@comcast.netMedical StudiesMessaging/Communications
31
28 Hunter Jamerson
Hunter JamersonMacaulay & Jamerson, P.C.Hunter@macjamlaw.comLegal
32
29Kim Hansen, R.Ph.Town & Country Compounding Pharmacynjcompounder@yahoo.comMessaging/CommunicationsMobilization/Grassroots
33
30Jay McEniryFagron North Americajay.mceniry@fagron.comAdvocacy [Lobbying]LegalCoalition-BuildingMessaging/Communications
34
31Tom Wynn RPhFagron North Americatom.wynn@fagron.comMedical StudiesSteering CommitteeCoalition-BuildingMessaging/Communications
35
32Kristen Youngdahl Pharm DBelmar Pharmacykristen@belmarpharmacy.comMessaging/CommunicationsSteering CommitteeMedical StudiesMobilization/Grassroots
36
33Rachel PontikesAttorney w Reed Smithrpontikes@reedsmith.comLegal
37
34Jennifer Burch, PharmDCentral Compounding Center/APCjburch@centralcompounding.comMedical StudiesMobilization/GrassrootsLegal
38
35Jeffrey Baird, Esq.Brown & Fortunato, P.C.jbaird@bf-law.comLegalAdvocacy [Lobbying]Steering CommitteeCoalition-Building
39
36Bradley W. Howard, Esq.Brown & Fortunato, P.C.bhoward@bf-law.comLegalAdvocacy [Lobbying]Steering CommitteeCoalition-Building
40
37David Brownstein MDacudoccc@hotmail.comMedical Studies
41
38Ronna HauserNCPAronna.hauser@ncpa.orgSteering Committee
42
39Peter Mihalick, Esq.NCPApeter.mihalick@ncpa.orgSteering CommitteeAdvocacy [Lobbying]Legal
43
40Sara Hover, RPhPCCAshover@pccarx.comMessaging/Communications
44
42Amy ShankPCCAashank@pccarx.comAdvocacy [Lobbying]Mobilization/Grassroots
45
43Sabrina Griggs RPhApothecary Shoppeapothecaryshoppe@hotmail.comMedical StudiesMessaging/Communications
46
44Ronald SuttonCompounder's International Analytical Labrsutton@compounderslab.com
47
45Jodi PetersonPrecision Compounding Pharmacyjodi@pcrxomaha.comMobilization/GrassrootsMessaging/CommunicationsCoalition-Building
48
46Jeffery BrayMedQuest Pharmacyjbray@mqrx.comAdvocacy
49
47Compounding Pharmacy of Americamatthew@compoundingrxusa.comCoalition buildingMedical StudiesMobilizationMessaging
50
48Tara Thompson, PharmD.Innovation Compounding Pharmacytthompson@innovationcompounding.comMessaging/CommunicationMobilization/ Grass RootsAdvocacy
51
49 Angela DeRosa DO MBA CPE
Belmar Pharma Solutionsdrderosa@belmarpharmacy.comCertification, Standards of Care
52
50Janeen Kochan PhDAviation Researchkochan@aviation-research.netmedical studies
53
5lShay Pausaforherhealthshay@forherhealth.com
Messaging/Communication
Mobilization/ Grass Roots
54
52Karen Leggett DOdrleggett@drkarenleggett.comMobilization/ Grass RootsMobilization/ Grass Rootsstandards
55
53Holly Papanek M.D.drholly@organichormonetherapy.com
56
54
Tenille Davis, PharmD RPh BCSCP
Civic Center Pharmacytenille@civiccenterpharmacy.comMobilization/GrassrootsMessaging/Communications
57
55Deborah Matthew MDdrmatthew@signaturewellness.orgcertification/standards of careMessaging/communications
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100